Abacavir Sulfate: CAS Registry Number 188062-50-2

Abacavir sulfate, chemically defined as CAS number 188062-50-2, serves as a powerful HIV medication. It suppresses the proliferation of the human immunodeficiency virus (HIV) by stopping the viral enzyme reverse transcriptase. This enzyme plays a vital role in the HIV life cycle, enabling the virus to integrate its genetic material into the host's

read more

Pharmacological Properties of Abacavir Sulfate (188062-50-2)

Abacavir sulfate acts as a nucleoside reverse transcriptase inhibitor utilized in the therapy of human immunodeficiency virus disease. Its therapeutic properties stem from the competitive inhibition of reverse transcriptase, an enzyme vital for HIV replication. Abacavir sulfate is a pro-drug that experiences conversion to its active form, carbovir

read more

Top-Tier API Manufacturer & Supplier

In today's rapidly evolving technological landscape, reliable and high-performance APIs are essential for businesses of all sizes. A leading global API manufacturer and supplier offers a comprehensive portfolio of cutting-edge APIs designed to meet the diverse needs of modern applications. With a proven commitment to quality, innovation, and custom

read more

Pharmacological Properties of Abacavir Sulfate (188062-50-2)

Abacavir sulfate is a nucleoside analog reverse transcriptase inhibitor. Its mechanism of action involves the competitive inhibition of HIV-1 reverse transcriptase, an enzyme crucial for viral replication. Abacavir sulfate exerts its effects by being incorporated into the growing DNA chain during reverse transcription, leading to premature stopping

read more

A Leading Nutraceutical API Producer

India has firmly established itself as a global hub for nutraceutical ingredient manufacturing, particularly in the realm of Active Pharmaceutical Ingredients (compounds). Numerous domestic firms specialize in the specialized production of wellness compounds, serving both the national market and exporting globally. These firms boast advanced facili

read more